Striatal shape alteration as a staging biomarker for Parkinson’s Disease
Parkinson’s Disease provokes alterations of subcortical deep gray matter, leading to subtle changes in the shape of several subcortical structures even before the manifestation of motor and non-motor clinical symptoms. We used an automated registration and segmentation pipeline to measure this struc...
Main Authors: | , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2020-01-01
|
Series: | NeuroImage: Clinical |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2213158220301091 |
id |
doaj-b33da8a300614d4bb1dc5adeeea4c171 |
---|---|
record_format |
Article |
spelling |
doaj-b33da8a300614d4bb1dc5adeeea4c1712020-11-25T04:01:39ZengElsevierNeuroImage: Clinical2213-15822020-01-0127102272Striatal shape alteration as a staging biomarker for Parkinson’s DiseaseMaxime Peralta0John S.H. Baxter1Ali R. Khan2Claire Haegelen3Pierre Jannin4INSERM, LTSI – UMR 1099, University of Rennes, Rennes, FranceINSERM, LTSI – UMR 1099, University of Rennes, Rennes, FranceImaging Research Laboratories, Robarts Research institute, Western University, London, CanadaINSERM, LTSI – UMR 1099, University of Rennes, Rennes, France; CHU Rennes, Rennes, FranceINSERM, LTSI – UMR 1099, University of Rennes, Rennes, France; Corresponding author.Parkinson’s Disease provokes alterations of subcortical deep gray matter, leading to subtle changes in the shape of several subcortical structures even before the manifestation of motor and non-motor clinical symptoms. We used an automated registration and segmentation pipeline to measure this structural alteration in one early and one advanced Parkinson’s Disease (PD) cohorts, one prodromal stage cohort and one healthy control cohort. These structural alterations are then passed to a machine learning pipeline to classify these populations. Our workflow is able to distinguish different stages of PD based solely on shape analysis of the bilateral caudate nucleus and putamen, with balanced accuracies in the range of 59% to 85%. Furthermore, we compared the significance of each of these subcortical structure, compared the performances of different classifiers on this task, thus quantifying the informativeness of striatal shape alteration as a staging bio-marker for PD.http://www.sciencedirect.com/science/article/pii/S2213158220301091Parkinson’s diseaseMorphometric biomarkersMachine learningStaging biomarkerMedical imaging |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Maxime Peralta John S.H. Baxter Ali R. Khan Claire Haegelen Pierre Jannin |
spellingShingle |
Maxime Peralta John S.H. Baxter Ali R. Khan Claire Haegelen Pierre Jannin Striatal shape alteration as a staging biomarker for Parkinson’s Disease NeuroImage: Clinical Parkinson’s disease Morphometric biomarkers Machine learning Staging biomarker Medical imaging |
author_facet |
Maxime Peralta John S.H. Baxter Ali R. Khan Claire Haegelen Pierre Jannin |
author_sort |
Maxime Peralta |
title |
Striatal shape alteration as a staging biomarker for Parkinson’s Disease |
title_short |
Striatal shape alteration as a staging biomarker for Parkinson’s Disease |
title_full |
Striatal shape alteration as a staging biomarker for Parkinson’s Disease |
title_fullStr |
Striatal shape alteration as a staging biomarker for Parkinson’s Disease |
title_full_unstemmed |
Striatal shape alteration as a staging biomarker for Parkinson’s Disease |
title_sort |
striatal shape alteration as a staging biomarker for parkinson’s disease |
publisher |
Elsevier |
series |
NeuroImage: Clinical |
issn |
2213-1582 |
publishDate |
2020-01-01 |
description |
Parkinson’s Disease provokes alterations of subcortical deep gray matter, leading to subtle changes in the shape of several subcortical structures even before the manifestation of motor and non-motor clinical symptoms. We used an automated registration and segmentation pipeline to measure this structural alteration in one early and one advanced Parkinson’s Disease (PD) cohorts, one prodromal stage cohort and one healthy control cohort. These structural alterations are then passed to a machine learning pipeline to classify these populations. Our workflow is able to distinguish different stages of PD based solely on shape analysis of the bilateral caudate nucleus and putamen, with balanced accuracies in the range of 59% to 85%. Furthermore, we compared the significance of each of these subcortical structure, compared the performances of different classifiers on this task, thus quantifying the informativeness of striatal shape alteration as a staging bio-marker for PD. |
topic |
Parkinson’s disease Morphometric biomarkers Machine learning Staging biomarker Medical imaging |
url |
http://www.sciencedirect.com/science/article/pii/S2213158220301091 |
work_keys_str_mv |
AT maximeperalta striatalshapealterationasastagingbiomarkerforparkinsonsdisease AT johnshbaxter striatalshapealterationasastagingbiomarkerforparkinsonsdisease AT alirkhan striatalshapealterationasastagingbiomarkerforparkinsonsdisease AT clairehaegelen striatalshapealterationasastagingbiomarkerforparkinsonsdisease AT pierrejannin striatalshapealterationasastagingbiomarkerforparkinsonsdisease |
_version_ |
1724445956537057280 |